CS logo
small CS logo
James Paget University Hospital

Great Yarmouth, United Kingdom
Hospital in England
Lowestoft Road Gorleston-on-Sea, Great Yarmouth NR31 6LA

About James Paget University Hospital


James Paget University Hospital is at Gorleston-on-Sea, Great Yarmouth, Norfolk, England, on the A47 Lowestoft Road. It is managed by the James Paget University Hospitals NHS Foundation Trust.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Aimmune Therapeutics, Inc.
3
Eli Lilly and Company
2
Hoffmann-La Roche
2
University College, London
2
University Hospital Southampton NHS Foundation Trust
2
Anglia Ruskin University
1
Boehringer Ingelheim
1
Chordate Medical
1
EBMT Solid Tumors Working Party
1
H. Lundbeck A/S
1
Institute of Cancer Research, United Kingdom
1
Total Rows: 33

Clinical Trials at James Paget University Hospital


During the past decade, James Paget University Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11113333224422111100000011111122Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
1995-03-01
Unknown status
200
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
2001-10-01
Unknown status
850
Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma
2003-01-01
2016-02-17
Completed
454
Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
2005-12-16
2024-09-01
Active, not recruiting
4,400
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
2005-09-01
Completed
148
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2006-09-01
2013-03-01
Completed
1,110
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
2006-08-01
Completed
2,000

Rows per page:

1–39 of 39

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "James Paget University Hospital" #1 sponsor was "Aimmune Therapeutics, Inc." with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "James Paget University Hospital" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Action Medical Research" with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAimmune Therapeutics, Inc.: 3Aimmune Therapeutics, Inc.: 3Eli Lilly and Company: 2Eli Lilly and Company: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2University College, London: 2University College, London: 2University HospitalSouthampton NHSFoundation Trust: 2University HospitalSouthampton NHSFoundation Trust: 2Anglia Ruskin University: 1Anglia Ruskin University: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Chordate Medical: 1Chordate Medical: 1EBMT Solid TumorsWorking Party: 1EBMT Solid TumorsWorking Party: 1H. Lundbeck A/S: 1H. Lundbeck A/S: 1

Created with Highcharts 11.1.0Top CollaboratorsPfizer: 2Pfizer: 2Action Medical Research: 1Action Medical Research: 1Applied HealthResearch Centre: 1Applied HealthResearch Centre: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Cambridge UniversityHospitals NHSFoundation Trust: 1Cambridge UniversityHospitals NHSFoundation Trust: 1Cancer Research UK: 1Cancer Research UK: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Imperial College London: 1Imperial College London: 1Institute of CancerResearch, UnitedKingdom: 1Institute of CancerResearch, UnitedKingdom: 1King's College London: 1King's College London: 1

Clinical Trials Conditions at James Paget University Hospital


According to Clinical.Site data, the most researched conditions in "James Paget University Hospital" are "Breast Cancer" (3 trials), "Lymphoma" (3 trials), "Peanut Allergy" (3 trials), "Diabetic Macular Edema" (2 trials) and "Diffuse Large B Cell Lymphoma" (2 trials). Many other conditions were trialed in "James Paget University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at James Paget University Hospital


Most popular intervention types in "James Paget University Hospital" are "Drug" (26 trials), "Biological" (8 trials), "Other" (8 trials), "Procedure" (8 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "cyclophosphamide" (3 trials), "AR101 powder provided in capsules & sachets" (2 trials), "Faricimab" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

Clinical Trials Genders at James Paget University Hospital


The vast majority of trials in "James Paget University Hospital" are 37 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at James Paget University Hospital


Currently, there are NaN active trials in "James Paget University Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in James Paget University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in James Paget University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 22Phase 3: 22Phase 2: 8Phase 2: 8Not Applicable: 3Not Applicable: 3Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 24Completed: 24Unknown status: 6Unknown status: 6Recruiting: 5Recruiting: 5Active, not recruiting: 3Active, not recruiting: 3Enrolling by invitation: 1Enrolling by invitation: 1